Research progress on the radiotherapy treatment of brain metastases from non-small cell lung cancer
10.3760/cma.j.cn113030-20210323-00116
- VernacularTitle:非小细胞肺癌脑转移放射治疗进展
- Author:
Qiaolu ZHANG
1
;
Mingyan E
Author Information
1. 哈尔滨医科大学附属肿瘤医院放疗科，哈尔滨 150000
- Keywords:
Carcinoma, non-small cell lung;
Neoplasms, brain metastasis;
Radiotherapy
- From:
Chinese Journal of Radiation Oncology
2022;31(8):741-744
- CountryChina
- Language:Chinese
-
Abstract:
The incidence rate of lung cancer ranks second and the mortality rate ranks first in the world. Non-small cell lung cancer (NSCLC) is the main pathological type and is prone to brain metastasis. At present, the main treatment methods of brain metastases from NSCLC include surgery, radiotherapy, chemotherapy, molecular targeting and immunotherapy. Radiotherapy is a common local treatment of brain metastases. With the development of technology and drugs, how to combine radiotherapy with other treatments is a hot topic in clinical research. In this article, advances in radiotherapy for brain metastases from NSCLC were reviewed, aiming to provide reference for the selection of treatment options in clinical practice.
